Method of treating a skin condition
An improved method of treating a skin barrier condition is disclosed. The method involves identifying a target portion of skin on a person where treatment is desired and applying a low-pH composition to the target portion of skin. The low-pH composition contains an effective amount of a vitamin B 3 compound and has a pH of less than 5.0.
1. A method of treating psoriasis or atopic dermatitis, comprising:
a) identifying a target portion of skin on a person exhibiting a symptom of psoriasis or atopic dermatitis; and
b) applying a low-pH composition to the target portion of skin during a treatment period, wherein the low-pH composition comprises an effective amount of niacinamide, has a pH of about 2.5, and reduces the amount of S100-A7 [SEQ ID NO: 2] according to the S100-A7 Protein Measurement method.
2. The method of claim 1 , wherein the composition comprises about 0.01% to about 10% of niacinamide.
3. The method of claim 1 , wherein the composition downregulates S100A7 [SEQ ID NO: 1] relative to a control.
4. The method of claim 1 wherein the reduction in S100-A7 [SEQ ID NO: 2] is at least 10% more than a predicted additive amount of S100-A7 [SEQ ID NO: 2] reduction.
5. The method of claim 1 , wherein the composition comprises at least one additional skin care active selected from the group consisting of vitamins, minerals, peptides, sugar amines, sunscreens, oil control agents, flavonoid compounds, anti-oxidants, protease inhibitors, tyrosinase inhibitors, anti-inflammatory agents, moisturizing agents, exfoliating agents, skin lightening agents, anti-acne agents, anti-wrinkle agents, phytosterols, N-acyl amino acid compounds, antimicrobials, antifungals, and combinations thereof.
6. The method of claim 1 , wherein the composition comprises about 0.1% to about 10% of a stable fatty alcohol thickener.
7. The method of claim 6 , wherein the stable fatty alcohol thickener is selected from the group consisting of cetyl alcohols, stearyl alcohols, and combinations thereof.
8. A method of treating psoriasis or atopic dermatitis, comprising:
a) determining an effective amount of niacinamide and a pH for providing a reduction in the expression of S100 calcium binding protein A7 [SEQ ID NO: 1] by contacting keratinocytes with a composition comprising niacinamide and having a pH of about 2.5, and measuring the change in the amount of S100-A7 [SEQ ID NO: 2];
b) combining the effectives amount of niacinamide with a dermatologically acceptable carrier to make a skin care composition at the determined pH;
c) providing the skin care composition to a person exhibiting a symptom of psoriasis or atopic dermatitis; and
d) applying the composition to a portion of skin exhibiting the symptom of psoriasis or atopic dermatitis.
9. The method of claim 8 , wherein the effective amount of niacinamide is between 0.01% and 10%, by weight of the composition.
10. The method of claim 8 , wherein the skin care composition comprises at least one additional skin care active.
11. The method of claim 8 , wherein the composition reduces the S100-A7 level by at least 10% compared to a corresponding neutral pH composition.
12. The method of claim 1 , wherein the low-pH composition is free of neutralized thickeners.